Today on Medscape

Top Stories from Across Medicine
 
 

Top Medical News from Across Medscape

  • Demand for Medical Specialists Increasing in USDemand for primary care physicians remains strong, but organizations are increasingly looking for medical specialists, a new Merritt Hawkins report finds.
  • FDA Clears First Point-of-Care Test to Diagnose DiabetesThe Afinion HbA1c Dx assay, for use with the Afinion AS100 Analyzer, is the first rapid point-of-care test cleared to diagnose diabetes and assess a patient's risk of developing the disease.
  • Scars of Childhood Stress Visible in the BrainEarly childhood stress has long-lasting effects, but the neurodevelopment trajectories are unclear. A study shows early childhood stress accelerates normal brain maturation, while adolescent stress delays it.
  • Eptinezumab Safe, Effective for Migraine PreventionA single dose of eptinezumab, which targets calcitonin gene-related peptide, provides rapid efficacy lasting up to 3 months in the prevention of chronic migraine, say PROMISE-2 investigators.

Ask the Experts

 

Columnists

Business of Medicine

Medscape Drugs & Diseases

  • Anxiety Disorders A 2018 study found that about 45% of people with depressive disorders and 30% of those with anxiety also have autoimmune thyroiditis.
  • Case: Age 48, Dyspnea & Cyanotic Skin? A 48-year-old man presents with coughing, nonradiating chest pressure, and increasing difficulty breathing. History is notable for hypertension and hyperlipidemia. Can you make the diagnosis?

Advisory Board

 

Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Executive Vice President and Professor of Molecular Medicine, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape